Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pattern
Austin, Texas, United Statespattern.bio ↗
- Ownership
- Private
- Employees
- ~85
- Development stage
- Other
01
Overview
Pattern Bioscience is a biotechnology company specializing in rapid diagnostic solutions for infectious diseases. The company's proprietary Digital Phenotyping platform utilizes single-cell microbiology and machine learning to identify pathogens and determine their antibiotic susceptibility in hours rather than days. This technology is designed to combat antimicrobial resistance and improve patient outcomes in critical care settings, such as sepsis management. By providing fast, phenotypic results directly from clinical samples, Pattern Bioscience enables clinicians to initiate targeted therapy much earlier.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Device
- Industry
- Pathology
Beyond the preview
Go deeper on Pattern.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pattern.